SCHEMBL7769221

SCHEMBL7769221

COc1ccccc1N1CCN(CC(N)c2nc3ccccc3s2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.48
DRD3 P35462 3/20 0.48
DRD4 P21917 1/20 0.48
RECQL P46063 1/20 0.47
IGF1R P08069 1/20 0.47
RAB9A P51151 2/20 0.47
ALDH1A1 P00352 1/20 0.47
TSHR P16473 1/20 0.47
PPARG P37231 1/20 0.47
NCOA2 Q15596 1/20 0.47
NCOA1 Q15788 1/20 0.47
NCOA3 Q9Y6Q9 1/20 0.47
DRD1 P21728 2/20 0.47
LPAR2 Q9HBW0 2/20 0.46
NPC1 O15118 1/20 0.46
HTR1A P08908 2/20 0.46
NR1I2 O75469 1/20 0.46
LMNA P02545 1/20 0.46
NR3C1 P04150 1/20 0.46
ADRB1 P08588 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7773336 0.92 HTR1A (0.48) DRD2DRD3ALDH1A1DRD1HTR1A
SCHEMBL7776873 0.90 HTR1A (0.52) DRD2DRD3HTR1A
SCHEMBL7856186 0.89 DRD3 (0.49) DRD2DRD3RECQLALDH1A1HTR1A
Bromide SCHEMBL7775404 0.89 HTR1A (0.51) DRD2DRD3HTR1A
SCHEMBL7769227 0.88 ALDH1A1 (0.48) DRD2DRD3RECQLIGF1RRAB9A
Bromide SCHEMBL7773368 0.88 ALDH1A1 (0.47) DRD2DRD3RECQLIGF1RRAB9A
SCHEMBL7773359 0.86 HTR2A (0.47) DRD2DRD3RECQLALDH1A1TSHR
SCHEMBL7776879 0.86 DRD2 (0.51) DRD2DRD3RAB9AALDH1A1NPC1
SCHEMBL7773392 0.86 CA1 (0.48) DRD2RAB9AALDH1A1HTR1AADRA2A
Bromide SCHEMBL7775386 0.85 CA1 (0.48) DRD2RAB9AALDH1A1HTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO claimed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP disclosed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO disclosed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO disclosed